Ann: Cynata Therapeutics GvHD Clinical Trial & Corporate Progress, page-50

It is still a risk until the report comes through as a positive result.

And then after that you have to commercialize the product, which is the second big hurdle.

Anyone whom suggests it's a done deal is erring on the positive. You are all sitting on the fence until the results are confirmed.

Risk is always going to exist in all businesses, fortunately you can mitigate risks in some businesses better than others, hedging etc with futures trading on commodity and mining indexes as an example.

There is a minimum hedge here, you're either bang on...or you're off the mark. Even mixed results will shift the price down.

But DYODD and sit with it.

Good luck.

Discussion is good tho. Food for thought.